{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T15:20:28Z","timestamp":1772119228418,"version":"3.50.1"},"reference-count":11,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2023,3,18]],"date-time":"2023-03-18T00:00:00Z","timestamp":1679097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,3,18]],"date-time":"2023-03-18T00:00:00Z","timestamp":1679097600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Cardiol"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1007\/s00246-023-03142-9","type":"journal-article","created":{"date-parts":[[2023,3,26]],"date-time":"2023-03-26T21:24:42Z","timestamp":1679865882000},"page":"836-844","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Assessing the Risk of Hypoglycemia Secondary to Propranolol Therapy for the Treatment of Supraventricular Tachycardia in Infants"],"prefix":"10.1007","volume":"44","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3340-096X","authenticated-orcid":false,"given":"N.","family":"Parker","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Flowers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Vickery","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Stolfi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Bugnitz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,3,18]]},"reference":[{"key":"3142_CR1","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/J.IPEJ.2019.09.004","volume":"19","author":"C Srinivasan","year":"2019","unstructured":"Srinivasan C, Balaji S (2019) Neonatal supraventricular tachycardia. Indian Pacing Electrophysiol J 19:222\u2013231. https:\/\/doi.org\/10.1016\/J.IPEJ.2019.09.004","journal-title":"Indian Pacing Electrophysiol J"},{"key":"3142_CR2","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/J.EARLHUMDEV.2015.04.001","volume":"91","author":"PY Chu","year":"2015","unstructured":"Chu PY, Hill KD, Clark RH et al (2015) Treatment of supraventricular tachycardia in infants: analysis of a large multicenter database. Early Hum Dev 91:345\u2013350. https:\/\/doi.org\/10.1016\/J.EARLHUMDEV.2015.04.001","journal-title":"Early Hum Dev"},{"key":"3142_CR3","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1016\/J.AMJCARD.2017.02.017","volume":"119","author":"EH Bolin","year":"2017","unstructured":"Bolin EH, Lang SM, Tang X, Collins RT (2017) Propranolol versus digoxin in the neonate for Supraventricular tachycardia (from the pediatric health information system). Am J Cardiol 119:1605\u20131610. https:\/\/doi.org\/10.1016\/J.AMJCARD.2017.02.017","journal-title":"Am J Cardiol"},{"key":"3142_CR4","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/J.JPEDS.2014.08.067","volume":"166","author":"AL Barton","year":"2015","unstructured":"Barton AL, Moffett BS, Valdes SO et al (2015) Efficacy and safety of high-dose propranolol for the management of infant Supraventricular tachyarrhythmias. J Pediatr 166:115\u2013118. https:\/\/doi.org\/10.1016\/J.JPEDS.2014.08.067","journal-title":"J Pediatr"},{"key":"3142_CR5","doi-asserted-by":"publisher","first-page":"II21","DOI":"10.1161\/01.HYP.11.3_PT_2.II21","volume":"11","author":"WH Frishman","year":"1988","unstructured":"Frishman WH (1988) \u03b2-adrenergic receptor blockers: adverse effects and drug interactions. Hypertension 11:II21\u2013II29. https:\/\/doi.org\/10.1161\/01.HYP.11.3_PT_2.II21","journal-title":"Hypertension"},{"key":"3142_CR6","doi-asserted-by":"publisher","DOI":"10.1542\/PEDS.2018-3475\/37268","author":"DP Krowchuk","year":"2019","unstructured":"Krowchuk DP, Frieden IJ, Mancini AJ et al (2019) Clinical practice guideline for the management of infantile hemangiomas. Pediatrics. https:\/\/doi.org\/10.1542\/PEDS.2018-3475\/37268","journal-title":"Pediatrics"},{"key":"3142_CR7","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1056\/NEJMOA1404710\/SUPPL_FILE\/NEJMOA1404710_DISCLOSURES.PDF","volume":"372","author":"C L\u00e9aut\u00e9-Labr\u00e8ze","year":"2015","unstructured":"L\u00e9aut\u00e9-Labr\u00e8ze C, Hoeger P, Mazereeuw-Hautier J et al (2015) A Randomized, Controlled trial of oral propranolol in infantile hemangioma. N Engl J Med 372:735\u2013746. https:\/\/doi.org\/10.1056\/NEJMOA1404710\/SUPPL_FILE\/NEJMOA1404710_DISCLOSURES.PDF","journal-title":"N Engl J Med"},{"key":"3142_CR8","doi-asserted-by":"publisher","DOI":"10.1542\/PEDS.2016-0353\/52332","author":"C L\u00e9aute-Labr\u00e8ze","year":"2016","unstructured":"L\u00e9aute-Labr\u00e8ze C, Boccara O, Degrugillier-Chopinet C et al (2016) Safety of oral propranolol for the treatment of infantile hemangioma: a systematic review. Pediatrics. https:\/\/doi.org\/10.1542\/PEDS.2016-0353\/52332","journal-title":"Pediatrics"},{"key":"3142_CR9","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1542\/PEDS.2012-1691","volume":"131","author":"BA Drolet","year":"2013","unstructured":"Drolet BA, Frommelt PC, Chamlin SL et al (2013) Initiation and use of propranolol for infantile hemangioma: report of a consensus conference. Pediatrics 131:128\u2013140. https:\/\/doi.org\/10.1542\/PEDS.2012-1691","journal-title":"Pediatrics"},{"key":"3142_CR10","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1111\/PDE.14651","volume":"38","author":"ML Johansen","year":"2021","unstructured":"Johansen ML, Mahendran G, Lawley LP (2021) Is prolonged monitoring necessary? an updated approach to infantile hemangioma treatment with oral propranolol. Pediatr Dermatol 38:800\u2013805. https:\/\/doi.org\/10.1111\/PDE.14651","journal-title":"Pediatr Dermatol"},{"key":"3142_CR11","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1111\/BJD.16779","volume":"179","author":"L Solman","year":"2018","unstructured":"Solman L, Glover M, Beattie PE et al (2018) Oral propranolol in the treatment of proliferating infantile haemangiomas: British society for paediatric dermatology consensus guidelines. Br J Dermatol 179:582\u2013589. https:\/\/doi.org\/10.1111\/BJD.16779","journal-title":"Br J Dermatol"}],"container-title":["Pediatric Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00246-023-03142-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00246-023-03142-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00246-023-03142-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,30]],"date-time":"2023-03-30T22:05:22Z","timestamp":1680213922000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00246-023-03142-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,18]]},"references-count":11,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,4]]}},"alternative-id":["3142"],"URL":"https:\/\/doi.org\/10.1007\/s00246-023-03142-9","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-2534105\/v1","asserted-by":"object"}]},"ISSN":["0172-0643","1432-1971"],"issn-type":[{"value":"0172-0643","type":"print"},{"value":"1432-1971","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,18]]},"assertion":[{"value":"31 January 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 March 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 March 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This retrospective chart review study involving human participants was in accordance with the ethical standards of the institutional and national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. The Human Investigation Committee (IRB) of University B approved this study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}